NCT00145210View on ClinicalTrials.gov

Safety and Efficacy of Nebivolol in the Treatment of Hypertension in African Americans

PHASE3CompletedINTERVENTIONAL
Enrollment

630

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Hypertension
Interventions
DRUG

Nebivolol and Atenolol

Trial Locations (1)

26505

Mylan Pharmaceuticals Inc., Morgantown

Sponsors
All Listed Sponsors
lead

Mylan Bertek Pharmaceuticals

INDUSTRY